BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
新型二十烷酸阿南达胺的生物合成
基本信息
- 批准号:2122673
- 负责人:
- 金额:$ 16.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-07-15 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:G protein amidases antisense nucleic acid arachidonate biological signal transduction cannabinoids cell type diacylglycerols dimethylsulfoxide drug receptors eicosanoid metabolism enzyme inhibitors enzyme linked immunosorbent assay ethanolamines laboratory mouse neuropharmacology phospholipase A2 phospholipase D phospholipids radioimmunoassay radiotracer receptor binding receptor coupling stimulant /agonist tissue /cell culture
项目摘要
The main goal of this application is to characterize the process involved
in agonist-stimulated synthesis of anandamide (arachidonylethanolamine) in
intact cells. A preliminary report (8) from this laboratory showed that
agents capable of activating phospholipases to release free arachidonic
acid appear to also promote anandamide synthesis. This observation has
provided the basis for the hypothesis that we wish to test in this
proposal, namely, that physiological control of anandamide synthesis
resides in the regulation of cellular phospholipase activity. This is the
situation for the other members of the eicosanoid family of which
anandamide is a novel member.
Anandamide has been suggested to be a putative endogenous cannabimimetic
substance, however, its significance will probably extend beyond the area
of drug abuse. Indeed, it has been speculated that it may represent a
class of novel neuroregulatory agents because of its distribution and
biological effects. Receptors that bind anandamide have also been observed
in peripheral cells associated with the immune system suggesting that it
may have functions outside of the central nervous system as well. Thus, an
understanding of how its tissue levels are controlled becomes a matter of
some importance.
Specific questions to be addressed in this proposal are; (a) What are the
agonists that are able to stimulate anandamide synthesis? (b) Are cells
in culture suitable experimental models for such studies; (c) Are
receptors required for synthesis in intact cells? (d) Which enzymic
mediators are responsible for anandamide synthesis? (e) What are the
important precursors for cellular anandamide synthesis?
Based on what is known about anandamide's properties, its significance may
be that it is involved in novel neuroregulatory processes that control CNS
functions such as mood, motor coordination, cognitive ability, time-sense
and self-perception. In addition, peripheral effects on the
cardiovascular, immune, endocrine and respiratory systems may also be part
of anandamides' spectrum of activities. The proposed studies may provide
useful models for the development of therapeutic approaches to diseases
such as multiple sclerosis, Huntington's, etc. where the use of
cannabinoids has been explored. Methods for controlling endogenous
anandamide synthesis in vivo could prove to be beneficial in relieving the
symptoms of these types of ailments. Finally, it is possible that
anandamide is only one member of a family of regulatory agents and that
data resulting from this project will provide evidence for the existence of
other more potent or specific "anandamides".
这个应用程序的主要目标是描述所涉及的过程
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUMNER HOWARD BURSTEIN其他文献
SUMNER HOWARD BURSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUMNER HOWARD BURSTEIN', 18)}}的其他基金
The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
- 批准号:
7727687 - 财政年份:2009
- 资助金额:
$ 16.13万 - 项目类别:
The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
- 批准号:
7894890 - 财政年份:2009
- 资助金额:
$ 16.13万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
7106374 - 财政年份:2004
- 资助金额:
$ 16.13万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
6951593 - 财政年份:2004
- 资助金额:
$ 16.13万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
6749403 - 财政年份:2004
- 资助金额:
$ 16.13万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
7678732 - 财政年份:2004
- 资助金额:
$ 16.13万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6175550 - 财政年份:1999
- 资助金额:
$ 16.13万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
2902241 - 财政年份:1999
- 资助金额:
$ 16.13万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6378830 - 财政年份:1999
- 资助金额:
$ 16.13万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6515659 - 财政年份:1999
- 资助金额:
$ 16.13万 - 项目类别:
相似海外基金
Periplasmic amidases in bacterial cell division.
细菌细胞分裂中的周质酰胺酶。
- 批准号:
2097254 - 财政年份:2018
- 资助金额:
$ 16.13万 - 项目类别:
Studentship
Investigating trivalent chelates as inhibitors of bacterial amidases
研究三价螯合物作为细菌酰胺酶抑制剂
- 批准号:
497252-2016 - 财政年份:2016
- 资助金额:
$ 16.13万 - 项目类别:
University Undergraduate Student Research Awards
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
- 批准号:
8912086 - 财政年份:2014
- 资助金额:
$ 16.13万 - 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
- 批准号:
8702797 - 财政年份:2014
- 资助金额:
$ 16.13万 - 项目类别:
Development of adjunctive therapies directed at S. aureus amidases
针对金黄色葡萄球菌酰胺酶的辅助疗法的开发
- 批准号:
8800543 - 财政年份:2014
- 资助金额:
$ 16.13万 - 项目类别:
NOVEL AMIDASES FOR SYNTHETIC ORGANIC CHEMISTRY
用于合成有机化学的新型酰胺酶
- 批准号:
6211089 - 财政年份:2000
- 资助金额:
$ 16.13万 - 项目类别:
DEVELOPMENT OF AMIDASES FOR B-LACTAM MODIFICATION
用于 B-内酰胺修饰的酰胺酶的开发
- 批准号:
3498043 - 财政年份:1988
- 资助金额:
$ 16.13万 - 项目类别:














{{item.name}}会员




